Please login to the form below

Not currently logged in
Email:
Password:

tobramycin

This page shows the latest tobramycin news and features for those working in and with pharma, biotech and healthcare.

CURx buys rights to Gilead’s lung infection drug

CURx buys rights to Gilead’s lung infection drug

Agrees deal for fosfomycin/tobramycin combination. CURx Pharmaceuticals has acquired the rights to Gilead Sciences' investigational drug for a lung infection associated with cystic fibrosis. ... Dinu Sen, CEO and founder of CURx, said that

Latest news

More from news
Approximately 3 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
infill healthcare communication

infill is a dynamic and innovative, international healthcare agency with >25 years' experience in delivering healthcare communication, medical education and...

Latest intelligence

50 questions for delivering an exceptional healthcare brand experience
Our 50-question brand planning checklist for healthcare ensures you deliver an exceptional experience, based on what your stakeholders want and need...
The brand strategy revolution
Introducing a new tool for developing a stakeholder-centric brand, based on the experience your patients and their HCPs want and need....
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....

Infographics